Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Adamas Pharma (NQ: ADMS)
9.830 USD  +0.020 (+0.20%)
Streaming Delayed Price  /  Updated: 11:16 AM EST, Dec 11, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 48,707
Open 10.00
Bid (Size) 9.800 (1)
Ask (Size) 9.840 (3)
Prev. Close 9.810
Today's Range 9.780 - 10.00
52wk Range 9.030 - 44.00
Shares Outstanding 26,982,322
Dividend Yield N/A
Performance
YTD
-72.43%
-72.43%
1 Month
-14.22%
-14.22%
3 Month
-56.81%
-56.81%
6 Month
-64.72%
-64.72%
1 Year
-72.29%
-72.29%
Top News
More News
Adamas to Present at Three November Investor Conferences
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced that Gregory T. Went,... Read More
from GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within Apptio, Adamas Pharmaceuticals, NEXEO SOLUTIONS, Computer Programs and, Solaris Oilfield Infrastructure, and SPX — New Research Emph
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Apptio Inc.... Read More
from GlobeNewswire News Releases
More News
Read More
Adamas Reports Third Quarter 2018 Financial Results
from GlobeNewswire News Releases
Bag This Deal Even Lower Than Chief Executive Officer Went Did
category Stocks
from Market News Video
Global Advanced Distribution Management Systems (ADMS) Market Size and Forecast 2018-2025: ABB Group, Schneider Electric SE, Siemens SE
from SBWire - Latest Press Releases
Adamas Pharmaceu Down 60.5% Since SmarTrend Downtrend Call (ADMS)
from Comtex SmarTrend® News Briefs
Analysts See 14% Gains Ahead For The Holdings of IWV
category ETFs
from ETF Channel
51.3% Return Seen to Date on SmarTrend Adamas Pharmaceu Call (ADMS)
from Comtex SmarTrend® News Briefs
10 Biggest Price Target Changes For Monday
category BABA , Analyst Ratings , ADVM , and 13 more.
from Benzinga
Adamas Pharmaceu Declining With Trend-Confirming Volume (ADMS)
from Comtex SmarTrend® News Briefs
Bearish Moving Average Cross by Adamas Pharmaceu (ADMS)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.